Effective treatment of β-thalassemia intermedia during pregnancy with rhuepo - A case report

Minerva Ginecologica

Volumn 52, Issue 1-2, 2000, Pages 29-31

  Lialios, G ^a   Makrydimas, G ^a   Tsanadis, G ^a   Lolls, D ^a   Bourantas, K ^a  

^a NONE   (Greece)

Author keywords

Beta thalassemia; Erythropoietin recombinant; Pregnancy complications

Indexed keywords

ANTIANEMIC AGENT; FOLIC ACID; IRON; RECOMBINANT ERYTHROPOIETIN;

ADULT; ANEMIA; ARTICLE; BETA THALASSEMIA; CASE REPORT; FEMALE; HUMAN; PREGNANCY;

ADULT; BETA-THALASSEMIA; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HUMANS; INFANT, NEWBORN; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC;

EID: 0034019180     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Weatherall DJ, Glegg J. The Thalassaemia syndrome. Oxford (UK): Blackwell Scientific Publications. 1980.
2. Rachmilewitz EA, Golbfarb A, Douer G. Administration of Epo to patients with β-thalassemia intermedia: a preliminary trial. Blood 1991;78:1145-7.
3. Bequin Y, Lipscei G, Oris R, Thoumsin H, Fillet G. Serum immunoreactive erythropoetin during pregnancy and in early poslpartum. Br J Haematol 1990;76:545-9.
4. White JM, Richards R, Byrne M, Buchanan T, White YS, lelenski G. Thalassemia trait and pregnancy. J Clin Pathol 1985;38:810-7.
5. Makrydimas G, Olis D, Lialios G, Tsiara S, Greorgou I. Burantas K. rHuepo treatment of post-partum anemia. Preliminary results, Eur J Obst Gyn Repr Biol 1998;81: 27-31.